This compound is an impurity reference standard for Acalabrutinib, a pharmaceutical intermediate. It is a brominated, amino-substituted imidazopyrazine derivative with a benzyl-protected pyrrolidine carboxylate structure.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Benzyl (2S)-2-(1-bromo-8-chloroimidazo[1,5-a]pyrazin-3-yl)pyrrolidine-1-carboxylate
pharmaceutical intermediate
Acalabrutinib Impurity 10
pharmaceutical intermediate
4-[5-[(2S)-1-but-2-ynoylpyrrolidin-2-yl]-10-methyl-12-oxo-4,6,9,13-tetrazatricyclo[7.4.0.02,6]trideca-1(13),2,4,7,10-pentaen-3-yl]-N-pyridin-2-ylbenzamide
pharmaceutical intermediate
5,6-Dihydroabiraterone
pharmaceutical intermediate
4-Cyano-2-fluorobenzyl alcohol
pharmaceutical intermediate
(S)-Oxetan-2-ylmethyl 4-methylbenzenesulfonate
pharmaceutical intermediate
Betti base hydrochloride
pharmaceutical intermediate
Benzyl 2-(8-amino-1-bromo-imidazo[1,5-a]pyrazin-3-yl)pyrrolidine-1-carboxylate
pharmaceutical intermediate
benzyl (2R)-2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)pyrrolidine-1-carboxylate
DLXYYJDQLZHBNU-CYBMUJFWSA-N
C1C[C@@H](N(C1)C(=O)OCC2=CC=CC=C2)C3=NC(=C4N3C=CN=C4N)Br
—
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.